Candidiasis, Invasive: Clinical Trials

5 trials for Candidiasis, Invasive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Withdrawn 1
Phase 21Withdrawn 1

Follow Candidiasis, Invasive: new trials by email Literature Review of Candidiasis, Invasive trials Research Report on Candidiasis, Invasive

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation
Micafungin - Invasive Candidiasis
Phase 1CompletedKevin Watt182013-01-012019-11-05
Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers
Fluconazole Loading Dose, Fluconazole Loading Dose & High Dose - Candidiasis
Phase 1CompletedDaniel Benjamin132008-11-012018-11-05
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia
hLF1-11, Placebo - Candidaemia
Phase 1 / Phase 2WithdrawnAM-Pharma2008-07-012015-06-30
Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Micafungin - Oropharyngeal Candidiasis, Candidemia
Phase 1CompletedAstellas Pharma Inc842007-10-142024-11-18
Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Micafungin (Mycamine) - Invasive Candidiasis, Esophageal Candidiasis
Phase 1CompletedAstellas Pharma Inc92007-10-012014-08-20

Narrower conditions

Candidemia (4)  ·  Candidiasis (3)  ·  Fungemia (1)  ·  Sepsis (1)  ·  Torulopsis (1)

Broader conditions

Bacterial Infections and Mycoses (5)  ·  Infections (5)  ·  Invasive Fungal Infections (5)  ·  Mycoses (5)  ·  Inflammation (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Systemic Inflammatory Response Syndrome (4)  ·  Fungemia (3)  ·  Sepsis (3)  ·  Candidiasis (2)

Interventions

Micafungin (3)  ·  Fluconazole (1)  ·  lactoferrin (1-11), human (1)

Sponsors

Astellas Pharma Inc (2)  ·  AM-Pharma (1)  ·  Daniel Benjamin (1)  ·  Kevin Watt (1)

Countries

United States (4)  ·  Netherlands (1)  ·  South Africa (1)

Top investigators

Daniel Benjamin, MD (1)  ·  Kevin Watt, MD (1)  ·  Professor P.E. Verweij, MD, PhD (1)